IRIS Accounts Production v25.1.0.734 02604134 Board of Directors 1.5.23 30.4.24 30.4.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh026041342023-04-30026041342024-04-30026041342023-05-012024-04-30026041342022-06-30026041342022-07-012023-04-30026041342023-04-3002604134ns15:EnglandWales2023-05-012024-04-3002604134ns14:PoundSterling2023-05-012024-04-3002604134ns10:Director12023-05-012024-04-3002604134ns10:PrivateLimitedCompanyLtd2023-05-012024-04-3002604134ns10:SmallEntities2023-05-012024-04-3002604134ns10:AuditExempt-NoAccountantsReport2023-05-012024-04-3002604134ns10:SmallCompaniesRegimeForDirectorsReport2023-05-012024-04-3002604134ns10:SmallCompaniesRegimeForAccounts2023-05-012024-04-3002604134ns10:FullAccounts2023-05-012024-04-300260413412023-05-012024-04-3002604134ns10:Director22023-05-012024-04-3002604134ns10:RegisteredOffice2023-05-012024-04-3002604134ns5:CurrentFinancialInstruments2024-04-3002604134ns5:CurrentFinancialInstruments2023-04-3002604134ns5:Non-currentFinancialInstruments2024-04-3002604134ns5:Non-currentFinancialInstruments2023-04-3002604134ns5:ShareCapital2024-04-3002604134ns5:ShareCapital2023-04-3002604134ns5:RetainedEarningsAccumulatedLosses2024-04-3002604134ns5:RetainedEarningsAccumulatedLosses2023-04-3002604134ns5:NetGoodwill2023-05-012024-04-3002604134ns5:PlantMachinery2023-05-012024-04-3002604134ns5:NetGoodwill2023-04-3002604134ns5:NetGoodwill2024-04-3002604134ns5:NetGoodwill2023-04-3002604134ns5:PlantMachinery2023-04-3002604134ns5:PlantMachinery2024-04-3002604134ns5:PlantMachinery2023-04-3002604134ns5:WithinOneYearns5:CurrentFinancialInstruments2024-04-3002604134ns5:WithinOneYearns5:CurrentFinancialInstruments2023-04-30
REGISTERED NUMBER: 02604134 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 April 2024

for

O'Connor Pharmacies Limited

O'Connor Pharmacies Limited (Registered number: 02604134)

Contents of the Financial Statements
for the Year Ended 30 April 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


O'Connor Pharmacies Limited

Company Information
for the Year Ended 30 April 2024







DIRECTORS: Mr. N Chahal
Mr. D Chahal





REGISTERED OFFICE: Office 1
21 Hatherton Street
Walsall
WS4 2LA





REGISTERED NUMBER: 02604134 (England and Wales)





ACCOUNTANTS: Dhillon Accountants Limited
Chartered Accountants
Office 1
21 Hatherton Street
Walsall
WS4 2LA

O'Connor Pharmacies Limited (Registered number: 02604134)

Balance Sheet
30 April 2024

30.4.24 30.4.23
Notes £    £   
FIXED ASSETS
Intangible assets 4 563,589 -
Tangible assets 5 55,733 54,419
619,322 54,419

CURRENT ASSETS
Stocks 100,000 71,718
Debtors 6 922,571 873,928
Cash at bank and in hand 85,330 78,527
1,107,901 1,024,173
CREDITORS
Amounts falling due within one year 7 (1,111,468 ) (513,494 )
NET CURRENT (LIABILITIES)/ASSETS (3,567 ) 510,679
TOTAL ASSETS LESS CURRENT
LIABILITIES

615,755

565,098

CREDITORS
Amounts falling due after more than
one year

8

(184,109

)

-

PROVISIONS FOR LIABILITIES (13,933 ) (10,340 )
NET ASSETS 417,713 554,758

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 417,613 554,658
SHAREHOLDERS' FUNDS 417,713 554,758

O'Connor Pharmacies Limited (Registered number: 02604134)

Balance Sheet - continued
30 April 2024


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 15 April 2025 and were signed on its behalf by:





Mr. N Chahal - Director


O'Connor Pharmacies Limited (Registered number: 02604134)

Notes to the Financial Statements
for the Year Ended 30 April 2024


1. STATUTORY INFORMATION

O'Connor Pharmacies Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2023, is being amortised evenly over its estimated useful life of ten years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance and 15% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


O'Connor Pharmacies Limited (Registered number: 02604134)

Notes to the Financial Statements - continued
for the Year Ended 30 April 2024


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 14 (2023 - 7 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 May 2023 290,990
Additions 603,845
At 30 April 2024 894,835
AMORTISATION
At 1 May 2023 290,990
Charge for year 40,256
At 30 April 2024 331,246
NET BOOK VALUE
At 30 April 2024 563,589
At 30 April 2023 -

O'Connor Pharmacies Limited (Registered number: 02604134)

Notes to the Financial Statements - continued
for the Year Ended 30 April 2024


5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 May 2023 101,404
Additions 11,283
At 30 April 2024 112,687
DEPRECIATION
At 1 May 2023 46,985
Charge for year 9,969
At 30 April 2024 56,954
NET BOOK VALUE
At 30 April 2024 55,733
At 30 April 2023 54,419

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.4.24 30.4.23
£    £   
Trade debtors 169,551 87,044
Amounts owed by group undertakings - 157,576
Other debtors 753,020 629,308
922,571 873,928

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.4.24 30.4.23
£    £   
Bank loans and overdrafts 89,380 -
Trade creditors 533,760 203,885
Taxation and social security 137,281 93,205
Other creditors 351,047 216,404
1,111,468 513,494

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN
ONE YEAR
30.4.24 30.4.23
£    £   
Bank loans 184,109 -

O'Connor Pharmacies Limited (Registered number: 02604134)

Notes to the Financial Statements - continued
for the Year Ended 30 April 2024


9. RELATED PARTY DISCLOSURES

Included in other debtors are the balances due from the companies mentioned below as at 30 April 2024:

- Carters Green WB Properties Limited - £20,000 (2023 - £20,000)
- Carters Green Business Center Limited - £367,410 (2023 - £160,403)
- TCP Pharma Limited - £214,622 (2023 - 348,551)
- Pure Relief Limited - £8,400 (2023 - £8,400)


Included in other creditors are the balances due to the companies mentioned below as at 30 April 2024:

- TCP Huccle Limited - £89,641 (2023 - NIL)
- Ian Mcardle Limited - £56,044 (2023 - £23,828 Debit Balance)

The all above loans are interest free and repayable on demand.

Mr Navdeep Chahal and Mr Dalwinder Chahal are the directors of above mentioned companies as at 30 April 2024.

10. ULTIMATE CONTROLLING PARTY

The company's ultimate controlling party is Pillpharm Limited by virtue of their ownership of 100% of the issued share capital in the company.